Searchable abstracts of presentations at key conferences in endocrinology

ea0038p202 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2015

Predictors of glycaemic response and impact on weight and BP of dapagliflozin therapy in type 2 diabetes

Huang Feicong , McConnell Lyndsey , Sainsbury Christopher , Jones Gregory

Background: Dapagliflozin was the first SGLT2 inhibitor licensed in UK to improve glycaemic control in type 2 diabetes. The study aimed to assess impact of dapagliflozin on glucose, weight and BP and identify factors predictive of glycaemic response in a large cohort.Methods: Observational retrospective data collected on all patients prescribed dapagliflozin across primary and secondary care in two Scottish health board areas. HbA1c, weight, BP and conco...

ea0038p247 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2015

Is polycythaemia a marker of an increased cardiovascular risk in transmen?

Naing Aye , Lei Lily , Jones Katie , Barrett James , Seal Leighton

A retrospective single centre audit was conducted on the effects of polycythaemia in trans-male and native male.Polycythaemia is a recognised side effect of testosterone treatment. It could be viewed as a maker of excess testosterone action. We examined whether lipid profiles as a marker of cardiovascular risk differed in a population of polycythaemic transmen (TM) and native males (NM).Forty-six NM and 12 TM were identified to hav...

ea0038p459 | Thyroid | SFEBES2015

Qualitative analysis of ultrasound reports assessing radiological descriptors of thyroid nodules – a retrospective pilot audit

Artham Satish , Mamoojee Yaasir , Jones Sue , Lal Vikram , Nag Sath

Introduction: Thyroid Ultrasound (US) is the recommended first line investigation of suspected thyroid nodules. Specific radiological features, such as micro-calcification, low echogenicity, solid consistency, heterogeneity and ill-defined margins, raise the possibility of underlying malignancy. These findings together with fine needle aspiration cytology guide the management of thyroid nodules. The aim of this audit was to evaluate the quality and adequacy of thyroid US repor...

ea0035p951 | Steroid metabolism and action | ECE2014

Testosterone stimulates glucose uptake in HepG2 liver cells

Kelly Daniel , Akhtar Samia , Bowskill Susannah , Smallwood Zoe , Jones Hugh

Introduction: Testosterone deficiency is associated with an increased risk of type-2 diabetes (T2D) in men. Physiological testosterone replacement (TRT) improves insulin resistance and glycaemic control in hypogonadal men with T2D. The mechanisms underlying these actions remain unknown, but may be due in part to an effect on the liver as a major metabolic organ involved in glucose regulation. We have previously shown in testicular feminised mice, which have low testosterone le...

ea0031p49 | Clinical biochemistry | SFEBES2013

An unusual case of chronic liquorice ingestion presenting as hypokalemic paralysis

Hegde Pallavi , Ramappa Arun Jeenahalli , Bowen-Jones David

Long-term liquorice ingestion is a well-known cause of secondary hypertension and hypokalemia. However, its initial presentation with a very severe hypokalemia and rhabdomyolysis is exceedingly rare. We report a 46-year-old gentleman who presented with acute onset bilateral leg weakness. Medication included allopurinol, aminophylline, fluoxetine, gabapentin, omeprazole, and inhalers. He had a 40 pack year smoking history and drank alcohol heavily in the past.<p class="abst...

ea0031p211 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2013

The use of GLP-1 receptor agonists to manage unwanted weight gain in patients with ‘hypothalamic’ obesity secondary to structural pituitary pathology

Kyaw Ye , Mogford Julianne , Hordern Victoria , Russell-Jones David

Introduction:: The hypothalamus is intimately involved in weight homeostasis. Pituitary tumours and treatment for pituitary tumours has been well described to induce obesity in certain subjects presumably due hypothalamic irritation or dysfunction. This is often very challenging to treat.GLP-1 analogues have direct central effects and have been shown to be effective for weight loss in obese patients with and without diabetes mellitus.<p class="abstex...

ea0031p248 | Pituitary | SFEBES2013

Transcriptional regulation of C-type natriuretic peptide (CNP/Nppc) and its receptor guanylyl cyclase-B (GC-B/Npr2) in gonadotroph and somatolactotroph cell lines

Mirczuk Samantha , Jones Alexander , McGonnell Imelda , Fowkes Robert

C-type natriuretic peptide (CNP) has recently been implicated as a key meiotic arrest factor in oocytes, and mechanistic studies suggest that the transcriptional regulation of the CNP gene (Nppc) and of its receptor, GC-B (Npr2) is sensitive to gonadotrophin-dependent cAMP accumulation. We have shown CNP to be a major regulator of gonadotrophs in the pituitary, but have yet to establish how either Nppc or Npr2 are transcriptionally controlled locally. In the current study, the...

ea0031p278 | Pituitary | SFEBES2013

Unusual presentation of acromegaly and functioning pituitary gonadotrophinoma (FSHoma)

Pan Shwe Zin Chit , Bevan-Jones Richard , Mathews Anitha

Background: Gonadotroph adenomas are the most common non-functioning pituitary adenomas in adult1, 2. However, functioning gonadotrophinomas are rare. Here, we describe an unusual presentation of concurrent acromegaly and functioning FSHoma (FSH-secreting pituitary adenoma).A 39-year-old man presented with a vague visual disturbance to the optometrist and a bitemporal hemianopia was detected.Further questioning elicited ...

ea0030oc2.10 | Oral Communications 2 | BSPED2012

When is it justifiable to await venous thyroid function tests before starting thyroxine treatment in infants referred with capillary TSH elevation?

Pokrovska Tzveta , Jones Jeremy , Shaikh Guftar , Donaldson Malcolm

Background: In Scotland median age at notification with elevated capillary (c) TSH (>25 initially or >8 μ/l on repeat testing) is 10 (range 3–35) days. If cTSH elevation is >100 μ/l decompensated hypothyroidism (moderate: free (f) T4 5 −<10, severe: <5 pmol/l) is likely and thyroxine treatment should start without delay. If TSH elevation is mild the clinician may prefer to wait for venous (v) fT4 result and observe the infant’s pro...

ea0029p269 | Cardiovascular Endocrinology and Lipid Metabolism | ICEECE2012

Testosterone replacement therapy inhibits key enzymes of fatty acid synthesis in mouse liver

Brooke J. , Kelly D. , Akhtar S. , Muraleedharan V. , Jones T.

Fatty liver (Hepatic Steatosis) is common in men with type 2 diabetes mellitus (T2DM). Furthermore there is a high prevalence of testosterone deficiency (up to 40%) in this population. Testosterone replacement therapy (TRT) has been shown to reduce elevated serum liver transaminase levels in hypogonadal men. The testicular feminised (Tfm) mouse exhibits a non-functional androgen receptor (AR) and low circulating testosterone levels. We have previously shown that a high-fat die...